Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Filings indexed 1,253 across all filing types
Latest filing 2016-11-28 Regulatory Filings
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2016
Regulatory Filings
2016-11-28 English
FORM 4
Director's Dealing
2016-11-23 English
FORM 4
Director's Dealing
2016-11-21 English
FORM 4
Director's Dealing
2016-11-09 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement (a Settlement Agreement) between Masimo Corporation and Koninklijke Philips N.V., including financial terms and legal dispute resolutions. It also references a press release and supply agreement related to the settlement. There are no financial statements or comprehensive financial data typical of annual or quarterly reports. The document is not a full audit report, earnings release, or management discussion. It is a regulatory filing announcing a significant corporate event, specifically a settlement agreement and related disclosures. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (5826 characters) and detailed event description support this classification with high confidence.
2016-11-07 English
FORM 4
Director's Dealing
2016-11-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.